Vascular Patch Market - Segmented by Material (Biologic, and Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Cardiac Aneurysm,etc.,) and Geography - Growth, Trends, and Forecast (2018 - 2023)

Vascular Patch Market - Segmented by Material (Biologic, and Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Cardiac Aneurysm,etc.,) and Geography - Growth, Trends, and Forecast (2018 - 2023)

The vascular patch market is expected to grow at a CAGR of 8.4% over the forecast period. Rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases along with increasing adoption of biological patches is driving the market growth. However, the high cost associated with the surgical procedure, changing reimbursement environment and recent product failures and recalls can retard the market growth.

Rising geriatric population and the subsequent increase in the prevalence of vascular diseases

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. According to United States Census Bureau’s Statistics among the 7.3 billion people worldwide in 2015, an estimated 8.5 percent, or 617.1 million were aged 65 and older. The number of older people is estimated to increase by nearly 60% in next 15 years. And by 2030 the total number of people above age of 65 will be more than a billion, i.e. geriatric population will represent 12% of global population. And by 2050 this number will cross 1.6 billion or 16.7% of total population. The ageing is commonly associated with increased vascular rigidity and decreased vascular compliance. Furthermore, in geriatric population the incidence and prevalence of peripheral arterial disease (PAD), aortic disease, and venous thromboembolism (VTE) increase due to age-related alterations in vascular structure which are further compounded by longer exposure to cardiovascular disease (CVD) risk factors. Apart from rise in geriatric population and increase in surgical procedures, increasing adoption of biological patches is also driving the market expansion.

Product Failures and Recalls

In June 2016, Baxter healthcare issued a product recall notice concerning its product Vascu-Guard Peripheral Vascular Patch and sent and urgent product recall letters via post to its customers. The notice identified the affected product, problem and actions to be taken. The costumers were instructed to immediately discontinue the use of product. Baxter received reports for intraoperative or postoperative bleeding episodes after the use of the product and one report involved a case with a fatal outcome. Previously, in the year 2015 Baxter issued a recall for some specific product codes of Vascu-Guard vascular patch family, due to complaints received for difficulty in distinguishing the smooth from rough surface. Risk of product failures and frequent recalls have a negative effect on patient compliance and can hinder the market expansion during the forecast period. The other factors restraining the market growth are high cost associated with the procedure, changing reimbursement environment and Risk of immune response and serious complications.

North America Dominates the Vascular Patch Market

North America dominated the market with the largest revenue share in 2017. The large share of the North American region can be attributed to the high prevalence of cardiovascular diseases, the faster product approval procedures and high adoption rate of new technologies. However, driven by rising healthcare expenditure and presence of a wide patient pool the Asia pacific region is expected to witness high growth during the forecast period.

Key Developments in the Market

- Apr 2018 - Cardiva Medical gets expanded FDA indications for Vascade vascular closure system, for use in 5-7F femoral venous closures in addition to arterial closure

Major Players - Lemaitre Vascular, Inc., Baxter International, Inc., Maquet (subsidiary of Getinge AB), B.Braun Melsungen AG , W. L. Gore & Associates GmbH, Admedus Ltd., Cryolife, Inc., C. R. Bard, Inc., Edwards Lifesciences Corporation, Labcor Laboratórios , Cardiva Medical, Inc., and Terumo Corporation among others

Reasons to Purchase the Report

- Analyzing various perspectives of the global vascular patch market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players
- 3 months analyst support along with the Market Estimate sheet (in Excel)

Customization of the Vascular Patch Market Report

- This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Vascular Patch Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Vascular Patch Market Dynamics
6.1 Vascular Patch Market Drivers
6.1.1 Rapidly Growing Geriatric Population and the Subsequent Increase in the Prevalence of Vascular Diseases
6.1.2 Increasing Adoption of Biological Patches
6.2 Vascular Patch Market Restraints
6.2.1 High Cost Associated with the Procedure & Reimbursement Issues
6.2.2 Product Failures and Recalls
6.2.3 Risk of Immune Response and Serious Complications
6.3 Opportunities
6.4 Key Challenges
7. Vascular Patch Market Segmentation
7.1 By Material
7.1.1 Biologic Vascular Patches
7.1.2 Synthetic Vascular Patches
7.2 By Application
7.2.1 Carotid Endarterectomy
7.2.2 Aortic Aneurysms
7.2.3 Profundaplasty
7.2.4 Others
7.3 By Geography
7.3.1 North America Vascular Patch Market Size (2018 - 2023)
7.3.1.1 United States Vascular Patch Market Size (2018 - 2023)
7.3.1.2 Canada Vascular Patch Market Size (2018 - 2023)
7.3.1.3 Mexico Vascular Patch Market Size (2018 - 2023)
7.3.2 Europe Vascular Patch Market Size (2018 - 2023)
7.3.2.1 France Vascular Patch Market Size (2018 - 2023)
7.3.2.2 Germany Vascular Patch Market Size (2018 - 2023)
7.3.2.3 United Kingdom Vascular Patch Market Size (2018 - 2023)
7.3.2.4 Italy Vascular Patch Market Size (2018 - 2023)
7.3.2.5 Spain Vascular Patch Market Size (2018 - 2023)
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific Vascular Patch Market Size (2018 - 2023)
7.3.3.1 China Vascular Patch Market Size (2018 - 2023)
7.3.3.2 Japan Vascular Patch Market Size (2018 - 2023)
7.3.3.3 India Vascular Patch Market Size (2018 - 2023)
7.3.3.4 Australia Vascular Patch Market Size (2018 - 2023)
7.3.3.5 South Korea Vascular Patch Market Size (2018 - 2023)
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa Vascular Patch Market Size (2018 - 2023)
7.3.4.1 GCC Vascular Patch Market Size (2018 - 2023)
7.3.4.2 South Africa Vascular Patch Market Size (2018 - 2023)
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America Vascular Patch Market Size (2018 - 2023)
7.3.5.1 Brazil Vascular Patch Market Size (2018 - 2023)
7.3.5.2 Argentina Vascular Patch Market Size (2018 - 2023)
7.3.5.3 Rest of South America
8. Company Profiles & Competitive Landscape
8.1 Lemaitre Vascular
8.2 Baxter International
8.3 Maquet (Subsidiary of Getinge AB)
8.4 B.Braun
8.5 W. L. Gore & Associates
8.6 Admedus
8.7 Cryolife
8.8 C. R. Bard
8.9 Edwards Lifesciences
8.10 Labcor
8.11 Terumo Corporation
*List Not Exhaustive
9. Vascular Patch Market Future

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook